Contraceptive Use Declines After Breast Cancer Diagnosis Medtwitter - Breast Cancer HEAD TOPICS

Contraceptive Use Declines After Breast Cancer Diagnosis

10/23/2022 4:17:00 AM

For women who do not wish to become pregnant contraceptive use after breast cancer diagnosis and treatment should be a priority especially given restrictive access to abortions in many states

Medtwitter Breast Cancer

Source

Medscape

Contraceptive use declined significantly after treatment for early breast cancer . More than half of women reported using contraceptives at the time of diagnosis, but at 1 year that percentage had declined to less than 40%. MedTwitter For women who do not wish to become pregnant contraceptive use after breast cancer diagnosis and treatment should be a priority especially given restrictive access to abortions in many states .In recent years,"some concerning signals have emerged" suggesting that many pregnancies among breast cancer survivors are unintended, which explains, at least in part,"the high rate of induced abortions described among breast cancer survivors," study author Matteo Lambertini, MD, PhD, of the University of Genova, Italy, and colleagues wrote. Given this, Lambertini and colleagues wanted to better understand contraceptive use among women with breast cancer.The current analysis used data from the CANTO study, which included 2744 women diagnosed with stage I-III breast cancer in France between March 2012 and December 2017. The researchers analyzed data collected at different time points"to provide distinct insights on contraceptive use and factors associated with contraceptive use over time." Read more:
Medscape » After losing 3 sisters to breast cancer, 'Pink Fireman' on mission to raise awareness Mom of 3 credits influencer with saving her life by sharing breast cancer diagnosis Former Penn State Linebacker Dies at 34 Making Strides Against Breast Cancer

Rivals com - Making the Case Five-star Cormani McClain

Read more >> After losing 3 sisters to breast cancer, 'Pink Fireman' on mission to raise awarenessMarshal Moneymaker's Three sisters – Vicky, Penny and Valessa – all died of breast cancer in the span of two years. Now, he's on a new mission: raising awareness of breast cancer as 'The Pink Fireman.' Mom of 3 credits influencer with saving her life by sharing breast cancer diagnosisThis mom of three went from following an influencer on Instagram to crediting the woman with saving her life. Former Penn State Linebacker Dies at 34Former Penn State linebacker Bani Gbadyu died early Saturday morning at the age of 34 due to complications from pancreatic cancer 🙏🏽 RIP Sad. Making Strides Against Breast CancerOctober is Breast Cancer Awareness Month and early detection through mammograms is one of the best defenses. Talk to your doctor or other health care provider about when to start and how often to get a mammogram. Carly Simon Loses Two Sisters to Cancer in One WeekJoanna Simon, a former opera singer, died from thyroid cancer, and Broadway composer Lucy Simon lost her battle with breast cancer . If you have never heard the original cast recording of 'The Secret Garden'...it's one of the most gorgeous works of music I've ever heard. And it was a privilege to see it live on Broadway back in the day. Once-in-a-lifetime mix of perfect music with perfect cast. Oh no. So sorry.🥰🥰🥰🥰🥰 Ugh yikes the study .MONTGOMERY COUNTY, Md.Young women take to social media to share breast cancer diagnoses, raise awareness October 3, 2022 The posts, and a series of Instagram stories Chatwin shared, spurred Williams to call her doctor and request a mammogram.Former Penn State Linebacker Bani Gbadyu Dies at 34 Author: Publish date: Oct 22, 2022 Former Penn State linebacker Bani Gbadyu died early Saturday morning at Hershey Medical Center in Pennsylvania at the age of 34 due to complications from pancreatic cancer. In recent years,"some concerning signals have emerged" suggesting that many pregnancies among breast cancer survivors are unintended, which explains, at least in part,"the high rate of induced abortions described among breast cancer survivors," study author Matteo Lambertini, MD, PhD, of the University of Genova, Italy, and colleagues wrote. Given this, Lambertini and colleagues wanted to better understand contraceptive use among women with breast cancer. "It has a pump, a tank of water and has a hose,” said retired firefighter Marshall Moneymaker. The current analysis used data from the CANTO study, which included 2744 women diagnosed with stage I-III breast cancer in France between March 2012 and December 2017. She's not in the statistics,'" said Williams. The researchers analyzed data collected at different time points"to provide distinct insights on contraceptive use and factors associated with contraceptive use over time. I've driven her on a few calls." At the time of diagnosis, more than half of women (54.  Latest NCAAF News. 2%) reported contraceptive use, 63% of whom used hormonal birth control. "The beauty of the story is, it actually served in the same station that I did,” he said of the truck." MORE: Mom of 2 battles breast cancer while pregnant Williams said the mammogram and further testing revealed she had stage 2 ductal carcinoma breast cancer that had metastasized to her lymph nodes. Participants were a mean age of 43 years. Primary treatment included chemotherapy in about 71% of participants, and endocrine therapy in about 80%." The bright pink fire truck now serves with Moneymaker on a new mission – raising awareness of breast cancer as"The Pink Fireman. The use of contraception significantly decreased 1 year after diagnosis to nearly 39% of patients (911 of 2342) and 2 years after diagnosis to 41% of women (808 of 1961). "Because Delia posted and because I listened to my own intuition about my own body, I'm going to be in a position now where I'm going to be alive for my kids and I'm going to be OK," said Williams. Most patients at year 1 (94. "While I was on the job, I lost three of my seven sisters to breast cancer," he said. 2%) and year 2 (95.3%) reported use of nonhormonal methods, including reversible mechanical methods, such as copper intrauterine devices and male condoms. "I didn't know I was dealing with mental issues or processing things until a breast cancer walk set up a pit stop in our firehouse," Moneymaker said. Williams and Chatwin have since become closer friends and have supported each other through their breast cancer journeys, which for Chatwin has included radiation and a mastectomy, in addition to chemotherapy. At 1 year after diagnosis, 45% of patients reported consulting with a gynecologist during the prior year, and at year 2, almost two thirds of patients reported doing so. After adjustment for numerous variables, factors significantly associated with contraceptive use at 1 year included contraception use at diagnosis (adjusted odds ratio [aOR], 4. I went to Walmart and found the funniest pink pajamas I could find and, you know, just put an ensemble together, so to speak.02), younger age (aOR, 1."Just because you're young and healthy, it doesn't matter. 09 per decreasing year of age), better sexual function (aOR, 1. "Me getting my own fire truck – I like to think that's the sisters involved, you know?" Moneymaker said.13), already having children (aOR, 4.21), the presence of leukorrhea (aOR, 1. "I love this truck! I love this truck! I am so proud of this truck because this truck is more than just a truck,” Shannon Moneymaker said. The disease can affect women of all ages, though most breast cancers are diagnosed in women ages 50 and older, according to the CDC .32), treatment with single-agent tamoxifen (aOR, 1.39), and consulting with a gynecologist during the prior year (aOR, 1." Their foundation helps those with breast cancer facing financial hardships. 29). Similar factors were associated with contraceptive use at 2 years, but at that time, still being partnered was also significantly associated with contraceptive use (aOR, 1. For them, October is go time.61), the authors noted. The findings are notable given earlier diagnoses and longer lifespans among cancer survivors, which make future pregnancies and reproductive health in general more relevant than in the past. That means they travel to numerous outreach events - with their Golden Retriever ambassador, Hope -- and let people know they can help. "Among premenopausal patients, reproductive health is an important component of survivorship care," the authors wrote. "These data support the clinical utility of promoting a more structured referral network that links oncologists and gynecologists, which may ensure not only access to fertility preservation strategies but also provide comprehensive long-term follow-up care. "I was treated for breast cancer like seven years ago, almost eight now," Davenport said." The current results also"highlight the importance of specialized comprehensive contraceptive counseling to aid in the selection of reliable methods and decrease the risk of unintended pregnancies." Lustberg agreed, adding that the"findings underscore the need to protect women by making conversations about contraceptive choices a priority." The work also includes making sure kids aren't forgotten, either." Contraceptive choices are already limited after cancer because hormonal contraceptives are often not an option, she explained. For women who do wish to become pregnant later, it is important to plan ahead. As for what his sisters might think of all that he has done, The Pink Fireman has one hope. "It takes planning and resources, and [these discussions] need to be more ingrained in the care of these women," she said. And although CANTO is a French study, the findings"very much resonate in terms of what happens in the United States," Lustberg said. For more information on For 3 Sisters, click here. "A more structured and coordinated system that links oncologists, gynecologists, and primary care clinicians is essential to providing long-term follow-up care to the increasing number of breast cancer survivors," she added. The CANTO study is supported by grants from the Investment for the Future program of the National Research Agency of France. Lambertini reported receiving personal fees from AstraZeneca, Eli Lilly and Co, Gilead Sciences, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and others and served as an advisor for some of these companies outside the submitted work. Lustberg reported no conflicts of interest. JAMA Network Open. .